NYSE: DXCDXC Technology Co Stock
$17.39-0.12 (-0.69%)
Updated Mar 27, 2025
DXC Price
$17.39
Fair Value Price
N/A
Market Cap
$3.15B
52 Week Low
$14.79
52 Week High
$24.83
P/E
-56.1x
P/B
1.05x
P/S
0.28x
PEG
N/A
Dividend Yield
N/A
Revenue
$13.09B
Earnings
-$75.00M
Gross Margin
23.9%
Operating Margin
1.93%
Profit Margin
-0.6%
Debt to Equity
3.27
Operating Cash Flow
$1B
Beta
1.46
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
DXC Overview
DXC Technology Company offers IT consulting services in the U.S. and internationally. DXC was created by the amalgamation of Computer Sciences Corporation and Hewlett Packard Enterprise's Services business in 2017 and is headquartered in Ashburn, VA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine DXC's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Information Technology Service
Industry Rating
A
DXC
Ranked#16 of 58
Ranked#16 of 58
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $25.24 | A | |
| $13.17 | A | |
| $111.36 | A |
Be the first to know about important DXC news, forecast changes, insider trades & much more!
DXC News
Overview
Due Diligence Score
–
Industry Average (36)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how DXC scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
DXC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
DXC is good value based on its book value relative to its share price (1.05x), compared to the US Information Technology Services industry average (5x)
P/B vs Industry Valuation
DXC is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more DXC due diligence checks available for Premium users.
Valuation
DXC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-56.1x
Industry
28.31x
Market
31.08x
DXC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.05x
Industry
5x
DXC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
DXC's financial health
Profit margin
Revenue
$3.2B
Net Income
$57.0M
Profit Margin
1.8%
DXC's Earnings (EBIT) of $253.00M... subscribe to Premium to read more.
Interest Coverage Financials
DXC's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$13.0B
Liabilities
$9.8B
Debt to equity
3.27
DXC's short-term assets ($5.08B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DXC's long-term liabilities ($5.99B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DXC's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
DXC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$650.0M
Investing
-$85.0M
Financing
-$68.0M
DXC's operating cash flow ($1.36B)... subscribe to Premium to read more.
Debt Coverage Financials
DXC vs Information Technology Service Stocks
DXC Technology Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.